Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$7,124,431
+$995,346 QoQ
Shares Held
28,312
+0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#1,100
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GUYASUTA INVESTMENT ADVISORS INC holds $53,362,618 across 9 Drug Manufacturers - General names. ABBV ranks #3 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
102,689 | $26,079,925 | |
| 2 | MRK |
Merck & Co., Inc.
|
65,671 | $8,438,723 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
28,312 | $7,124,431 | |
| 4 | LLY |
ELI LILLY & Co
|
2,574 | $3,087,333 | |
| 5 | PFE |
Pfizer Inc
|
113,231 | $2,726,602 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,071 | $2,654,611 | |
| 7 | NVS |
Novartis AG
|
10,767 | $1,687,404 | |
| 8 | AMGN |
Amgen Inc
|
3,642 | $1,318,841 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,124,431 | 28,312 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $6,129,085 | 28,181 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $6,449,130 | 28,225 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $6,534,984 | 28,224 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $5,458,156 | 29,405 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $6,052,613 | 28,888 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $5,397,992 | 30,377 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $6,042,295 | 30,597 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,361,029 | 31,256 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $5,691,717 | 31,256 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $4,843,742 | 31,256 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $4,846,089 | 32,511 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $4,275,926 | 31,737 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $5,086,134 | 31,914 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $5,182,347 | 32,067 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $4,285,056 | 31,928 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $4,876,308 | 31,838 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $6,011,849 | 37,085 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $5,128,139 | 37,874 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,085,468 | 37,874 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $4,050,759 | 35,962 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,720,278 | 34,377 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,636,028 | 33,934 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,936,191 | 33,522 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $2,998,122 | 30,537 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,804,941 | 23,690 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||